Výsledky vyhledávání - "Gregg C. Sylvester"

Akademický článek

Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications

Autor: Constantina Boikos, Mahrukh Imran, Van Hung Nguyen, Thierry Ducruet, Gregg C. Sylvester, James A. Mansi

Publikováno v: Vaccines, Vol 9, Iss 8, p 862 (2021)

MF59®-adjuvanted trivalent inactivated influenza vaccine (aIIV3) and high-dose trivalent inactivated influenza vaccine (HD-IIV3) elicit an enhanced immune response in older adults compared to standard, quadrivalent inactivated influenza vaccines (II

Externí odkaz: https://doaj.org/article/799e06af1af2428b8fd40ca68202092d

Zobrazit plný text záznamu

Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017–2018 and 2018–2019 Influenza Seasons

Autor: Constantina Boikos, Lauren Fischer, James A. Mansi, Gregg C Sylvester, Daniel P O'Brien, Joseph Vasey

Publikováno v: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

Background The effectiveness of standard, egg-derived quadrivalent influenza vaccines (IIV4) may be reduced in adults ≥65 years of age, largely because of immunosenescence. An MF59-adjuvanted trivalent influenza vaccine (aIIV3) and a high-dose triv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84672cbf6e386b80615e85255ce33f4f
http://europepmc.org/articles/PMC8423477

Zobrazit plný text záznamu

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States

Autor: James A. Mansi, Constantina Boikos, Lauren Fischer, Joseph Vasey, Gregg C Sylvester, Daniel P O'Brien

Publikováno v: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

Background The cell-propagated inactivated quadrivalent influenza vaccine (ccIIV4) may offer improved protection in seasons where egg-derived influenza viruses undergo mutations that affect antigenicity. This study estimated the relative vaccine effe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2196d66cf8fd5eb2d731b581330378
http://europepmc.org/articles/PMC8326580

Zobrazit plný text záznamu

Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018

Autor: James A. Mansi, Gregg C Sylvester, Constantina Boikos, John S. Sampalis

Publikováno v: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

Background Influenza antigens may undergo adaptive mutations during egg-based vaccine production. In the 2017–2018 influenza season, quadrivalent, inactivated cell-derived influenza vaccine (ccIIV4) vaccine was produced using A(H3N2) seed virus pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::310e604fe5851068fdfaa9e67d8fc64a
https://doi.org/10.1093/cid/ciaa371

Zobrazit plný text záznamu

Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications

Autor: Gregg C Sylvester, Thierry Ducruet, Mahrukh Imran, Van Hung Nguyen, James A. Mansi, Constantina Boikos

Publikováno v: Vaccines, Vol 9, Iss 862, p 862 (2021)
Vaccines
Volume 9
Issue 8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76601dab82f854e7f128106e75d8df44
https://www.mdpi.com/2076-393X/9/8/862

Zobrazit plný text záznamu

Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season

Autor: James A. Mansi, Van Hung Nguyen, Thierry Ducruet, Constantina Boikos, Gregg C Sylvester, Mahrukh Imran

Publikováno v: Open Forum Infectious Diseases

Background Higher rates of influenza-related morbidity and mortality occur in individuals with underlying medical conditions. To improve vaccine effectiveness, cell-based technology for influenza vaccine manufacturing has been developed. Cell-derived

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f7b716e942ab5995aebb94ba535df8
http://europepmc.org/articles/PMC8314952

Zobrazit plný text záznamu

Plný text ve formátu HTML

LB-2. Relative Effectiveness of aIIV3 versus IIV4 and HD-IIV3 In Preventing Influenza-Related Medical Encounters in Adults ≥65 Years of Age at High Risk for Influenza Complications During the U.S. 2017–2018 and 2018–2019 Influenza Seasons

Autor: Lauren Fischer, Dan O'Brien, James A. Mansi, Gregg C Sylvester, Joseph Vasey

Publikováno v: Open Forum Infectious Diseases

Background Individuals with health conditions have shown higher rates of influenza-related morbidity and mortality compared to healthy individuals and are often prioritized for influenza vaccination. However, vaccination with egg-derived standard qua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::820b55cc2ad420d35a623ee608e562ed
http://europepmc.org/articles/PMC7776880

Zobrazit plný text záznamu

A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States

Autor: Edward Power, John M McLaughlin, Verna L. Welch, Nina M Hill, Eric A Utt, Gregg C Sylvester

Publikováno v: Human Vaccines & Immunotherapeutics

Previous research has suggested that reducing the US 4-dose PCV13 schedule to a 3-dose schedule may provide cost savings, despite more childhood pneumococcal disease. The study also stressed that dose reduction should be coupled with improved PCV adh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce070d0d0961f3bd6b6fe807da409ce8
https://pubmed.ncbi.nlm.nih.gov/26376039

Zobrazit plný text záznamu

Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects

Autor: Roger E. Stevenson, Kelley S. Scanlon, Gregg C. Sylvester, Robert H. Allen, James E. Cheek, M.J. Adams, Sally P. Stabler, James E. Haddow, George J. Knight, Muin J. Khoury, Judy P. Henry

Publikováno v: Teratology. 51:311-317

The role of folic acid in the primary prevention of neural tube defects (NTDs) is well established. However, questions related to the protective mechanism remain unanswered. To help answer these questions, we designed a case-control study to assess t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f726d4b9d429fba17ddfedf7484fdb10
https://doi.org/10.1002/tera.1420510507

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání